How many insider declarations has Dhruvalben V Shah filed?

Dhruvalben V Shah has filed 3 public insider declarations with SEBI (PIT + SAST).

What is Dhruvalben V Shah's role?

Dhruvalben V Shah's reported role is not specified by the regulator across the filings.

Which companies does Dhruvalben V Shah report trades for?

Dhruvalben V Shah reports trades for Remus Pharmaceuticals Limited.

← Executives ★ Sign in to follow

DV

Dhruvalben V Shah

·SEBI (PIT + SAST)

Remus Pharmaceuticals Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by Dhruvalben V Shah. Insider active across 1 company, notably Remus Pharmaceuticals Limited. In total, 3 disclosures have been recorded. Activity tracked since 3 June 2024. The latest transaction was disclosed on 11 December 2025 (Purchase). Regulator: SEBI (PIT + SAST). All data is free.

Companies and markets linked to Dhruvalben V Shah

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Remus Pharmaceuticals Limited (IN)IN insider transactions · SEBI (PIT + SAST)

Declarations3 total

●

DHRUVALBEN V SHAH

Executives11 Dec 2025Remus Pharmaceuticals Limited

₹360,5003SEBI ↗

500 shares@ ₹721.009.7% of flowEquity SharesSEBI:026fef6719e40deb77212a329355812dc464af21

●

DHRUVALBEN V SHAH

Executives7 Aug 2025Remus Pharmaceuticals Limited

₹170,9452SEBI ↗

200 shares@ ₹854.7254.7% of flowEquity SharesSEBI:39fe14adf6b4d9ff5c8eeabd2d3e3c565e432eab

●

DHRUVALBEN V SHAH

Executives3 Jun 2024Remus Pharmaceuticals Limited

₹3M10SEBI ↗

375 shares@ ₹7,316.130785.6% of flowEquity SharesSEBI:4978d18a221ba833e74afb7c5557591b777aa16e

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

DV

Dhruvalben V Shah

·SEBI (PIT + SAST)

Remus Pharmaceuticals Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by Dhruvalben V Shah. Insider active across 1 company, notably Remus Pharmaceuticals Limited. In total, 3 disclosures have been recorded. Activity tracked since 3 June 2024. The latest transaction was disclosed on 11 December 2025 (Purchase). Regulator: SEBI (PIT + SAST). All data is free.